Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial
Sign Up to like & getrecommendations! Published in 2018 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-018-6807-9
Abstract: PurposeSubclinical atrial fibrillation (AF) was found in a large number of pacemaker patients. It is not certain whether there is a similar risk/benefit ratio for oral anticoagulation in patients with subclinical AF compared to patients… read more here.
Keywords: anticoagulation; patients device; trial; detected subclinical ... See more keywords
When is Device-Detected Atrial Fibrillation Actionable?
Sign Up to like & getrecommendations! Published in 2018 at "Cardiac electrophysiology clinics"
DOI: 10.1016/j.ccep.2017.11.007
Abstract: Device-detected atrial high-rate episodes (AHREs) are frequently encountered in patients with no history of atrial fibrillation (AF) and represent a challenge for clinicians because patients with device-only documented AF have not been included in clinical… read more here.
Keywords: atrial fibrillation; device detected; fibrillation actionable; detected atrial ... See more keywords
Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT
Sign Up to like & getrecommendations! Published in 2021 at "Europace"
DOI: 10.1093/europace/euab116.139
Abstract: Type of funding sources: None. Atrial fibrillation (AF) that is first detected concurrently with or shortly after another cardiac event is often thought to be caused by acute cardiac injury, and therefore reversible. ASSERT enrolled… read more here.
Keywords: atrial fibrillation; acute cardiac; cardiac event; device detected ... See more keywords